
<ns0:uwmetadata xmlns:ns0="http://phaidra.univie.ac.at/XML/metadata/V1.0" xmlns:ns1="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0" xmlns:ns10="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0" xmlns:ns11="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0/entity" xmlns:ns12="http://phaidra.univie.ac.at/XML/metadata/digitalbook/V1.0" xmlns:ns13="http://phaidra.univie.ac.at/XML/metadata/etheses/V1.0" xmlns:ns2="http://phaidra.univie.ac.at/XML/metadata/extended/V1.0" xmlns:ns3="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/entity" xmlns:ns4="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/requirement" xmlns:ns5="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/educational" xmlns:ns6="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/annotation" xmlns:ns7="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/classification" xmlns:ns8="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/organization" xmlns:ns9="http://phaidra.univie.ac.at/XML/metadata/histkult/V1.0">
  <ns1:general>
    <ns1:identifier>o:3160</ns1:identifier>
    <ns1:title language="en">Asymptomatic patients with severe aortic stenosis and the impact of intervention</ns1:title>
    <ns1:language>en</ns1:language>
    <ns1:description language="en">ABSTRACT: Objectives the exact timing of aortic valve replacement (AVR) in asymptomatic patients with severe aortic stenosis (AS) remains a matter of debate. Therefore, we described the natural history of asymptomatic patients with severe AS, and the effect of AVR on long-term survival.
METHODS: Asymptomatic patients who were found to have severe AS between June 2006 and May 2009 were included. Severe aortic stenosis was defined as peak aortic jet velocity Vmax ≥ 4.0 m/s or
aortic valve area (AVA) ≤ 1 cm2. Development of symptoms, the incidence of AVR, and all-cause mortality were assessed. Results: A total of 59 asymptomatic patients with severe AS were followed, with a mean follow-up of 8.9 ± 0.4 years. A total of 51 (86.4%) patients developed AS related
symptoms, and subsequently 46 patients underwent AVR. The mean 1-year, 2-year, 5-year, and 10-year overall survival rates were higher in patients receiving AVR compared to those who did not undergo AVR during follow-up (100%, 93.5%, 89.1%, and 69.4%, versus 92.3%, 84.6%, 65.8%,
and 28.2%, respectively; p &lt; 0.001). Asymptomatic patients with severe AS receiving AVR during follow-up showed an incremental benefit in survival of up to 31.9 months compared to conservatively managed patients (p = 0.002). CONCLUSIONS: The majority of asymptomatic patients turn symptomatic during follow-up. AVR during follow-up is associated with better survival in asymptomatic severe AS patients.</ns1:description>
    <ns1:keyword language="en">Key words: aortic valve replacement, aortic stenosis, asymptomatic, early surgery, watchful waiting</ns1:keyword>
    <ns2:identifiers>
      <ns2:resource>91552100</ns2:resource>
      <ns2:identifier>128518665</ns2:identifier>
    </ns2:identifiers>
    <ns2:identifiers>
      <ns2:resource>1552101</ns2:resource>
      <ns2:identifier>2308-3425</ns2:identifier>
    </ns2:identifiers>
    <ns2:identifiers>
      <ns2:resource>1552099</ns2:resource>
      <ns2:identifier>10.3390/jcdd8040035</ns2:identifier>
    </ns2:identifiers>
  </ns1:general>
  <ns1:lifecycle>
    <ns1:upload_date>2023-10-30T14:12:20.404Z</ns1:upload_date>
    <ns1:status>44</ns1:status>
    <ns2:peer_reviewed>yes</ns2:peer_reviewed>
    <ns1:contribute seq="0">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Mevlüt</ns3:firstname>
        <ns3:lastname>Çelik</ns3:lastname>
        <ns3:conor>106302217</ns3:conor>
      </ns1:entity>
      <ns1:date>2021</ns1:date>
    </ns1:contribute>
    <ns1:contribute seq="1">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Milan</ns3:firstname>
        <ns3:lastname>Milojević</ns3:lastname>
        <ns3:conor>106163721</ns3:conor>
        <ns3:orcid>0000-0003-0984-9011</ns3:orcid>
      </ns1:entity>
      <ns1:date>2021</ns1:date>
    </ns1:contribute>
    <ns1:contribute seq="2">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Andras P.</ns3:firstname>
        <ns3:lastname>Durko</ns3:lastname>
      </ns1:entity>
    </ns1:contribute>
    <ns1:contribute seq="3">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Frans B. S. </ns3:firstname>
        <ns3:lastname>Oei</ns3:lastname>
      </ns1:entity>
    </ns1:contribute>
    <ns1:contribute seq="4">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Edris A. F. </ns3:firstname>
        <ns3:lastname>Mahtab</ns3:lastname>
      </ns1:entity>
    </ns1:contribute>
    <ns1:contribute seq="5">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Ad J. J. C. </ns3:firstname>
        <ns3:lastname>Bogers</ns3:lastname>
      </ns1:entity>
    </ns1:contribute>
  </ns1:lifecycle>
  <ns1:technical>
    <ns1:format>application/pdf</ns1:format>
    <ns1:size>730138</ns1:size>
    <ns1:location>https://unilib.phaidrabg.rs/o:3160</ns1:location>
  </ns1:technical>
  <ns1:rights>
    <ns1:cost>no</ns1:cost>
    <ns1:copyright>yes</ns1:copyright>
    <ns1:license>16</ns1:license>
  </ns1:rights>
  <ns1:classification>
    <ns1:purpose>70</ns1:purpose>
    <ns7:keyword language="en" seq="0">616.132-089</ns7:keyword>
  </ns1:classification>
  <ns1:organization>
    <ns8:hoschtyp>92000001</ns8:hoschtyp>
    <ns8:orgassignment>
      <ns8:faculty>71A11</ns8:faculty>
    </ns8:orgassignment>
  </ns1:organization>
  <ns12:digitalbook>
    <ns12:name_magazine language="en">Journal of cardiovascular development and disease</ns12:name_magazine>
    <ns12:volume>8</ns12:volume>
    <ns12:booklet>4</ns12:booklet>
    <ns12:from_page>1</ns12:from_page>
    <ns12:to_page>10</ns12:to_page>
    <ns12:releaseyear>2021</ns12:releaseyear>
  </ns12:digitalbook>
</ns0:uwmetadata>
